Janssen Korea to launch new protease inhibitor

Published: 2008-01-15 06:56:00
Updated: 2008-01-15 06:56:00
Janssen Korea says it will launch its new protease inhibitor Prezista (darunavir) sooner or later after being placed on the list of health insurance guaranteed products.

Prezista, which was approved by the U.S. Food and Drug Administration in July 2006, is active against many of the viruses re...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.